Glucose tolerance tests performed in 15 patients (10 males and 5 females, age range 6-34 years, mean 16 years) with transfusional iron overload revealed fasting and subsequent blood glucose concentrations within the normal range in all except one patient who was overtly diabetic. However, in all patients except one, blood glucose concentration at 2 hours was higher than the respective fasting glucose concentration. All but two of the patients (one of whom was diabetic) showed fasting and post glucose hyperinsulinism. All the patients had hepatic dysfunction of varying severity. It is hence suggested that the initial disturbance of carbohydrate metabolism in transfusional siderosis is insulin resistance, similar to that found in chronic liver disease. Overt diabetes is probably a later event, occurring when sufficient damage to pancreatic cells has occurred and appropriate hyperinsulinaemia cannot be sustained.
Impaired glucose tolerance and diabetes mellitus are known complications of transfusional iron overload. ' We undertook this study to investigate whether diminished insulin secretion due to pancreatic~cell damage or insulin resistance due to progressive hepatic damage is the major mechanism underlying impaired glucose tolerance in this condition. Our results show significant hyperinsulinism and insulin resistance in the majority of patients with severe transfusional iron overload and hepatic damage, and we conclude that this is an earlier and more frequent abnormality than diminished pancreatic~cell dysfunction.
Patients and methods liver biopsies. One patient had overt diabetes controlled with insulin.
An oral GTT was performed on all patients after an overnight fast; 1·75 glkg body weight of glucose was used for glucose challenge. Blood samples were obtained every 30 minutes for 2 hours through an indwelling needle for sequential glucose and immunoreactive insulin determinations. Similar glucose tolerance tests were also carried out on 10 normal subjects. Blood glucose was measured by the glucose oxidase method, and immunoreactive insulin by a radioimmunoassay kit (Radiochemical Centre, Amersham).
Since the distribution of data was non-parametric, the data from patients and controls were compared using the Mann-Whitney U test. Fifteen patients (10 males and 5 females age range 6-34 years, mean 16 years) with transfusional iron Results overload were included in this study. Fourteen had thalassaemia major and one had congenital red Concentrations of blood glucose, while fasting and cell aplasia and thalassaemia-HbE disease, re-after challenge with glucose, were found to be within spectively. The total blood transfused into each the normal reference range in all patients except one, patient ranged from 72 to 360 units and their serum who had overt diabetes. However, there was an ferritin concentration from 1740 to 24000, mean unexpected increase in blood glucose concentration 10 000 fJ-g/dl. All patients had significant hepato-at 120 minutes in seven out of 15 (47 %) patients, so cellular damage. Aspartate transaminase ranged that the 120 minute concentration was greater than between 28 and 117 U/I (normal range 4-15 U/I).
that at either 60 or 90 minutes by 1--4 mmol/l (see The liver histology showed cirrhosis in five, severe Figure) . Blood glucose concentration at 120 minutes fibrosis in nine, and minimal fibrosis in one patient. was also greater than fasting blood glucose in 14 out Evidence of severe iron overload was observed in all of 15 patients. Blood glucose and immunoreactive insulin (lRI) concentrations before and after glucose challenge. Note the biphasic increase in glucose (d) and lRl (b) in seven patients. All patients except two had fasting lRI concentration greater than 20 fLU/mi. IRI data were available in only 14 patients, seven of whom had a biphasic response (b) whereas the other seven had a normal response of blood glucose (c) and IRI (d) . Note that in seven out of eight patients in (c) 2 h post-challenge glucose readings were higher than the fasting ones.
Plasma glucose (mmolll) and serum immunoreactive insulin (lRI) concentrations (mU//) in thalassaemic patients and control subjects
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The data were non-parametric and hence are expressed as medians with ranges in parentheses.
Fasting immunoreactive insulin (IRI) concentration was greater than 20 mUll in all patients except two, one of whom was overtly diabetic, dependent on insulin. Both had fasting IRI con-centration greater than 15 mU /1. In our laboratory, the fasting concentration ofIRI is less than 10 mU /1 in normal children (n = 15) and in adults of normal weight (n = 40). Elevated IRI concentrations, such as those described in our thalassaemic patients, are usually observed in patients with obesity. After glucose challenge, serum IRI paralleled the blood glucose pattern, so that IRI at 120 minutes was greater than that at 60 or 90 minutes in the same patients as those who showed a biphasic rise after glucose challenge (see Figure) .
In the 10 control subjects studied, fasting plasma glucose concentrations and those after glucose challenge were not different from those observed in thalassaemic patients. None of the control patients, however, showed a biphasic increase in glucose concentrations as described above in half of the thalassaemic patients. The fasting and post-challenge serum IRI concentrations in normal subjects were consistently and significantly lower than those in thalassaemic patients (Table) .
There was no correlation between age, sex, number of units of blood transfused, and the degree of iron overload (as indicated by serum ferritin concentrations) and the degree of hyperinsulinism.
Discussion
Although blood glucose concentrations after a challenge with glucose remained within the normal reference range in all patients except the one with overt diabetes, the 120-minute glucose did not return to the fasting baseline in 14 out of 15 patients investigated. This fact, when associated with fasting and post-glucose hyperinsulinaemia, is suggestive of the presence of insulin resistance and a mild impairment of glucose tolerance. Fasting and post challenge hyperinsulinism was present in all patients except the one with overt diabetes. Even this patient had fasting and subsequent IRI concentrations comparable to those in normal controls. The actual mechanism underlying this hyperinsulinaemia is probably the diminished uptake of insulin by the chronically damaged liver, as has been shown by Johnstone et al. 2 The second rise of blood glucose at 120 minutes in seven patients is more intriguing. It could reflect either delayed absorption of glucose from the gut, impaired glycogenesis or enhanced glycogenolysis by the liver, or a combination of all three. Impaired glucose absorption would tend to give a flat glucose tolerance curve rather than a biphasic one, and there is no evidence hitherto that intestinal absorption is impaired in patients with iron overload.
It would thus appear that the initial and the most common defect in patients with iron overload is one of liver-mediated insulin resistance. This defect, in combination with some impairment of insulin secretion-as seen in the only overt diabetic in the 79 series-is probably the ultimate cause of diabetes in these patients. There are at least two previous studies in which the possible existence of insulin resistance was looked for in patients with iron overload. Whereas Kuo et af. 3 observed an impaired hypoglycaemic response to intravenously administered insulin, Toccafondi et al. 4 found neither fasting hyperinsulinaemia nor resistance to insulin given intravenously. A recent series by Zuppinger et al. 5 showed fasting and post-glucose insulin concentrations to be lower than normal in thalassaemic patients. However, in a previous study , Flynn et al? demonstrated hyperinsulinaemia in five out of 19 non-diabetic thalassaemic patients, three of whom later became diabetic. These discrepancies are probably the consequence of differences in the age of the patients, the extent of iron overload, and the relative magnitude of damage to the liver and the pancreas. Although it is difficult to compare the clinical state of patients from different series, it appears that those included in our series were at an earlier stage of damage induced by iron overload. This is probably the reason why ours is the first series demonstrating clearly the consistent presence of hyperinsulinism in patients with iron overload.
In the present series of patients, however, it can be concluded that the initial defect is that of insulin resistance due to chronic hepatic damage with a mild intolerance to glucose, which is compensated by an enhanced circulating concentration of insulin. Overt diabetes probably occurs only when significant pancreatic islet cell damage cannot sustain appropriate hyperinsulinaemia.
